WORLD HEALTH ORGANIZATION
No Indian study has shown pollution shortens life: Prakash Javadekar
Indian studies have not shown a correlation between shortening of life and pollution, the Minister for Environment, Forest and Climate Change said.
Parliamentary panel recommends integration of Indian Systems of Medicine with modern treatment
The Department-related Parliamentary Standing ...
Health Ministry questioned on delayed use of Oxytocin after childbirth
In an article published in the reputed British Medical Journal (BMJ), ...
What India can learn from other countries to beat air pollution
Faced with the hazard of deteriorating air composition, many countries like China have over the years adapted to technology and strategies to counter the crisis, including energy infrastructure optimisation, coal-fired pollution control, and emission controls.
Pollution won't spare your little one: Kids deemed more vulnerable to damage than adults
Kids these days are likely to face increased risk from severe floods, prolonged droughts, and wildfires.
Unable to afford insulin? This WHO initiative aims at helping diabetics by slashing prices
There are currently more than 420 million diabetic adults in the world.
India's children face lifelong health burden of climate change: Lancet report
If the world follows a business-as-usual pathway, with high carbon emissions and climate change continuing at the current rate, children born today will face a world that will be on average over 4 degrees Celsius warmer by their 71st birthday, threatening their health at every stage of their lives.
Regulator waives off clinical trials, clears Sanofi TB Drug
“We have recently received final approval for rifapentine from the Indian regulatory authorities. Rifapentine is now officially registered in India,” Thibaud Lefort, Sanofi’s global health business chief, told ET on the sidelines of the 50th Union World Conference of Lung Health in Hyderabad.
Our drug Ranitidine is safe: Strides Pharma
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. In India, a host of companies including GalxoSmithKline, JB Chemicals, Cadila Pharma, Zydus Cadila, Dr Reddy’s and Sun Pharmaceuticals sell over 180 versions of the drug. Strides Pharma is likely to resume drug sale, following the report.
Mumbai pharma company gets licence for breakthrough TB drug
A global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ‘breakthrough’ drug Pretomanid in high-burden countries, including India.
India continues to record maximum number of tuberculosis (TB) cases.
As per the report 10 million people had TB in 2018. While 26,90,000 people had TB in India, out of which 19,90,000 were notified.
View: Where the Global Hunger Index 2019 went wrong in India's case
The Global Hunger Index ranking doesn’t reflect significant improvements by India on four key indicators.
India sets quality standards for global potato trade
The standard guidelines cover all the commercial varieties of potatoes, considering shape, skin colour and flesh colour.
Mental health in India: 7.5% of country affected; less than 4,000 experts available
By next year, roughly 20 per cent of India will suffer from some form of mental illness.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service